Inhaltsbereich
| 164 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9 › » |
Seite 1 / 9
 Druckansicht
|
| Activity of T-DM1 in Her2-positive breast cancer brain metastases. |
| Bartsch R, Berghoff AS, Vogl U, Rudas M, Bergen E, Dubsky P, Dieckmann K, Pinker K, Bago-Horvath Z, Galid A, Oehler L, Zielinski CC, Gnant M, Steger GG, Preusser M |
| Clinical & experimental metastasis. 2015 Aug 25. doi: 10.1007/s10585-015-9740-3 |
| PMID: 26303828 |
| Bevacizumab: no comeback in early breast cancer? |
| Bartsch R, Gnant M, Steger GG |
| The Lancet. Oncology. 2015 Aug 10. pii: S1470-2045(15)00124-2. doi: 10.1016/S1470-2045(15)00124-2 |
| PMID: 26272771 |
| Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. |
| Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF |
| Lancet (London, England). 2015 May 31. pii: S0140-6736(15)60995-3. doi: 10.1016/S0140-6736(15)60995-3 |
| PMID: 26040499 |
| Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer. |
| Bergen E, Berghoff AS, Rudas M, Dubsky P, De Vries C, Sattlberger C, Mader RM, Zagouri F, Sparber C, Fitzal F, Gnant M, Rottenfusser A, Zielinski CC, Preusser M, Steger GG, Bartsch R |
| Breast care (Basel, Switzerland). 2015 Mar 11. doi: 10.1159/000368330. pii: brc-0009-0344. pmc: PMC4322687 |
| PMID: 25759615 |
| CDK4/6 inhibitors in luminal breast cancer. |
| Gnant M, Steger GG, Bartsch R |
| The Lancet. Oncology. 2014 Dec 16. pii: S1470-2045(14)71188-X. doi: 10.1016/S1470-2045(14)71188-X |
| PMID: 25524801 |
| Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol. |
| Pluschnig U, Haslik W, Bayer G, Soleiman A, Bartsch R, Lamm W, Steger GG, Zielinski CC, Mader RM |
| Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2014 Nov 30. doi: 10.1007/s00520-014-2535-2 |
| PMID: 25433440 |
| Indocyanine green video angiography predicts outcome of extravasation injuries. |
| Haslik W, Pluschnig U, Steger GG, Zielinski CC, Schrögendorfer KF, Nedomansky J, Bartsch R, Mader RM |
| PloS one. 2014 Aug 21. doi: 10.1371/journal.pone.0103649. pii: PONE-D-14-14898. pmc: PMC4140719 |
| PMID: 25144707 |
| Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients. |
| Berghoff AS, Bartsch R, Preusser M, Ricken G, Steger GG, Bago-Horvath Z, Rudas M, Streubel B, Dubsky P, Gnant M, Fitzal F, Zielinski CC, Birner P |
| Breast (Edinburgh, Scotland). 2014 Jul 10. pii: S0960-9776(14)00124-6. doi: 10.1016/j.breast.2014.06.011 |
| PMID: 25017122 |
| HER2-positive breast cancer: a new piece of the puzzle. |
| Gnant M, Bartsch R, Steger GG |
| The Lancet. Oncology. 2014 May 2. pii: S1470-2045(14)70192-5. doi: 10.1016/S1470-2045(14)70192-5 |
| PMID: 24793817 |
| Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24). |
| Steger GG, Greil R, Lang A, Rudas M, Fitzal F, Mlineritsch B, Hartmann BL, Bartsch R, Melbinger E, Hubalek M, Stoeger H, Dubsky P, Ressler S, Petzer AL, Singer CF, Muss C, Jakesz R, Gampenrieder SP, Zielinski CC, Fesl C, Gnant M |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013 Dec 16. pii: mdt508. doi: 10.1093/annonc/mdt508 |
| PMID: 24347519 |
| Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series. |
| Zagouri F, Sergentanis TN, Koutoulidis V, Sparber C, Steger GG, Dubsky P, Zografos GC, Psaltopoulou T, Gnant M, Dimopoulos MA, Bartsch R |
| British journal of cancer. 2013 May 30. pii: bjc2013255. doi: 10.1038/bjc.2013.255. pmc: PMC3681005 |
| PMID: 23722469 |
| Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial. |
| Pfeiler G, Stöger H, Dubsky P, Mlineritsch B, Singer C, Balic M, Fitzal F, Moik M, Kwasny W, Selim U, Renner K, Ploner F, Steger GG, Seifert M, Hofbauer F, Sandbichler P, Samonigg H, Jakesz R, Greil R, Fesl C, Gnant M |
| British journal of cancer. 2013 Mar 19. pii: bjc2013114. doi: 10.1038/bjc.2013.114. pmc: PMC3629426 |
| PMID: 23511562 |
| Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancer. |
| Berghoff AS, Bago-Horvath Z, Dubsky P, Rudas M, Pluschnig U, Wiltschke C, Gnant M, Steger GG, Zielinski CC, Bartsch R |
| The breast journal. 2013 Jan 27. doi: 10.1111/tbj.12070 |
| PMID: 23350584 |
| NF-κB addiction and resistance to 5-fluorouracil in a multi-stage colon carcinoma model. |
| Körber MI, Klingenbrunner S, Bartsch R, Steger GG, Mader RM |
| International journal of clinical pharmacology and therapeutics. 2012 Dec 24. pii: 10295 |
| PMID: 23259994 |
| Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors. |
| Berghoff AS, Bago-Horvath Z, Ilhan-Mutlu A, Magerle M, Dieckmann K, Marosi C, Birner P, Widhalm G, Steger GG, Zielinski CC, Bartsch R, Preusser M |
| British journal of cancer. 2012 Oct 9. pii: bjc2012440. doi: 10.1038/bjc.2012.440. pmc: PMC3493775 |
| PMID: 23047551 |
| Influence of the American ODAC statement on Austrian bevacizumab prescribing practice for metastatic breast cancer. |
| Preusser M, Fülöp G, Berghoff AS, Heinzl H, Steger GG, Greil R, Zielinski CC, Bartsch R |
| The oncologist. 2012 Jun 27. pii: theoncologist.2012-0115. doi: 10.1634/theoncologist.2012-0115. pmc: PMC3399659 |
| PMID: 22744818 |
| Treatment of Bone Metastases in Patients with Advanced Breast Cancer. |
| Gnant M, Balic M, Petru E, Raunik W, Singer CF, Steger GG, Watzke IM, Brodowicz T |
| Breast care (Basel, Switzerland). 2012 Apr 24. doi: 10.1159/000338650. pii: brc-0007-0092. pmc: PMC3376361 |
| PMID: 22740794 |
| Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer. |
| Bartsch R, Bago-Horvath Z, Berghoff A, DeVries C, Pluschnig U, Dubsky P, Rudas M, Mader RM, Rottenfusser A, Fitzal F, Gnant M, Zielinski CC, Steger GG |
| European journal of cancer (Oxford, England : 1990). 2012 Mar 27. pii: S0959-8049(12)00247-X. doi: 10.1016/j.ejca.2012.03.002 |
| PMID: 22459763 |
| Trends and Novel Approaches in Neoadjuvant Treatment of Breast Cancer. |
| Steger GG, Bartsch R |
| Breast care (Basel, Switzerland). 2011 Dec 15. doi: 10.1159/000335331. pii: brc-0006-0427. pmc: PMC3290012 |
| PMID: 22419895 |
| Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group. |
| Dubsky PC, Jakesz R, Mlineritsch B, Pöstlberger S, Samonigg H, Kwasny W, Tausch C, Stöger H, Haider K, Fitzal F, Singer CF, Stierer M, Sevelda P, Luschin-Ebengreuth G, Taucher S, Rudas M, Bartsch R, Steger GG, Greil R, Filipcic L, Gnant M |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Jan 23. pii: JCO.2011.36.8993. doi: 10.1200/JCO.2011.36.8993 |
| PMID: 22271481 |
| 164 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9 › » |
Seite 1 / 9
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
